CAHILL BRIAN JOSEPH (Chief Financial Officer) reported 1 transaction at EAGLE PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/20/2023ACC: 0001209191-23-059344
Officer· Chief Financial Officer
Since Oct 2020
-452.00
Net shares
Net seller
$2.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
452.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−452.00
Price / share
$4.76
Trade value
$2.15K
% of position
0.9%
12/18/2023
47.87K→47.42K
Total
Net shares
−452.00
Net value
-$2.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2023 | F · Tax Withholding | −452.00 | $4.76 | $2.15K | 0.9% | 47.87K | 47.42K |
| Total | −452.00 | -$2.15K | ||||||
Derivative Transactions0
No derivative transactions reported